Katherine Wang, MD

Articles by Katherine Wang, MD

Applying the Innovation Biodesign Framework to Promote Equity and Green Activity in Dementia Care

ByBecca Lassell, PhD, OTR,Katherine Wang, MD,Ada Metaxas, BS-C,Sarah Zwerling,Sara Hantgan, BSI-C,Prabhat Gottipati,Sunit P. Jariwala, MD, FAAAAI

April 30th 2024

Lassell et al present a use case demonstrating the process of moving an unmet need to the “solution space” of the Innovation Biodesign Framework for addressing a healthcare challenge in a specific at-risk population: Alzheimer disease and AD-related dementias.

Latest Updated Articles

FDA Approves Lecanemab Autoinjector, Marking First At-Home Treatment for Alzheimer Disease
Published: August 29th 2025 | Updated: September 2nd 2025
Indirect Comparison Study Hints at Lower ARIA and ICH-Related Mortality Risk in Lecanemab Over Donanemab
Published: July 28th 2025 | Updated: July 30th 2025
Observed Differences in PIRA Definition Call for More Standardized Agreement on Term
Published: May 14th 2025 | Updated: May 16th 2025
Serum Neurofilament Light Chain Limited in Predicting MOGAD Attacks but Correlates With Attack Severity
Published: May 12th 2025 | Updated: May 13th 2025
FDA Approves Diazoxide Choline Extended-Release Tablets for Hyperphagia in Prader-Willi Syndrome
Published: March 27th 2025 | Updated: March 28th 2025
BTK Inhibitor Tolebrutinib Shows Greater Effectiveness in Multiple Sclerosis with Higher Paramagnetic Rim Lesion Counts
Published: March 4th 2025 | Updated: March 19th 2025

Katherine Wang, MD

Articles by Katherine Wang, MD

Applying the Innovation Biodesign Framework to Promote Equity and Green Activity in Dementia Care

Latest Updated Articles

Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights

Daridorexant Provides Relief for Insomnia in Women During Menopausal Transition

RELIEV-CM Pilot Study Data Further Supports ShiraTronics’ Neuromodulation Device to Treat Chronic Migraine

New Study Finds Link Between Gut Hormone GLP-1 and NMOSD Symptoms, Paving Way for Targeted Treatments

International Committee Publishes 2024 Revisions to McDonald Diagnostic Criteria for Multiple Sclerosis

Stem Cells of Secondary Progressive Multiple Sclerosis Drive Increased Proinflammatory T-Cell Activity